Cancer is still the most common cause of death for men in the US ages 60 to 79 and women ages 40 to 79. For all adults ...

Cancer survival in the U.S. has climbed to 70%, reflecting major advances in treatment, early detection and personalized care ...

Women who received Elenagen plus chemotherapy lived significantly longer than those who received chemotherapy alone.

A new clinical study published in the International Journal of Gynecological Cancer reports encouraging results for women ...

A cancer diagnosis can feel like life is suddenly on a clock — but it doesn’t have to be. With the right strategy, many people are living longer, fuller lives even after diagnosis. While medical ...

Please provide your email address to receive an email when new articles are posted on . Neoadjuvant chemotherapy significantly lowered 90-day postoperative mortality for advanced ovarian cancer across ...

High-volume cancer centers with greater NACT use show reduced 90-day surgical mortality and improved 60-month survival for advanced-stage ovarian cancer patients. The study analyzed data from the ...

High-volume hospitals with frequent NACT use had the lowest 90-day surgical mortality and longest 60-month survival. NACT reduced perioperative deaths in all hospital types, including those with low ...